The pharmaceutical industry is evolving rapidly, with an increasing number of temperature-sensitive and advanced medicinal products entering the market. Biologics, vaccines and advanced therapies place stringent demands on maintaining product quality throughout the entire distribution process. As a result, traceability has evolved from a regulatory requirement into a strategic priority for the pharmaceutical supply chain.<\/p>\n
The EU Guidelines on Good Distribution Practice (GDP) are designed to ensure that medicinal products are stored, transported and distributed under controlled conditions. The framework requires documented processes, risk management and systems that enable effective product traceability and product recalls when necessary.<\/p>\n
In practice, however, these same principles create value that extends far beyond regulatory compliance.<\/p>\n
A More Proactive Approach to Risk Management<\/strong><\/p>\n Access to reliable data on temperature, location and product handling enables stakeholders to identify deviations at an early stage, strengthen quality assurance and make more informed decisions throughout the distribution chain. When information is shared between manufacturers, logistics providers and healthcare recipients, transparency increases and risks can be managed more proactively.<\/p>\n This perspective is also reflected in the World Health Organization\u2019s approach to traceability. WHO recognises modern traceability systems as an important tool for safeguarding the integrity of pharmaceutical supply chains, improving operational efficiency and enabling faster detection and management of quality deviations.<\/p>\n Digitalisation is accelerating this development. Real-time monitoring, automated documentation and integrated information flows not only support regulatory compliance but also contribute to higher quality, greater operational efficiency and increased resilience across an increasingly complex pharmaceutical supply chain.<\/p>\n The future of pharmaceutical logistics is therefore about more than meeting regulatory requirements. It is about leveraging traceability and data-driven insights to build safer processes, reduce risk and strengthen trust throughout the entire distribution chain\u2014from manufacturer to patient.<\/p>\n","protected":false},"featured_media":35946,"template":"","kategori":[],"class_list":["post-35953","nyhet","type-nyhet","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\n